Interaction of cigarette exposure and airway epithelial cell gene expression

Annual Review of Physiology

Volumn 73, Issue , 2011, Pages 437-456

  Brody, Jerome S ^a   Steiling, Katrina ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

COPD; field of injury; lung cancer

Indexed keywords

ALCOHOL DEHYDROGENASE; CIGARETTE SMOKE; CIGARETTE SMOKE CONDENSATE; CYTOCHROME C OXIDASE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; METALLOTHIONEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; PROTEIN P63; SCLEROPROTEIN; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CANCER GROWTH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; EMPHYSEMA; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; NONHUMAN; PASSIVE SMOKING; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

ANIMALS; CARCINOMA; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MALE; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; SMOKING; UNITED STATES;

EID: 79951784188     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-012110-142219     Document Type: Article

References (109)

1. EzzatiE, LopezA. 2000. Estimates of globalmortality attributable to smoking in 2000. Lancet 362:847-52
2. Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, et al. 2008. Surveillance for cancers associated with tobacco use-United States, 1999-2004. MMWR 57:1-33
3. World Health Organ. (WHO). 2008. WHO report on the global tobacco epidemic, WHO Health Rep., WHO, Geneva
4. Jemal A, Siegael R, Ward E, Hoa NY, Xu J, Thun MJ. 2009. Cancer statistics 2009. CA Cancer J. Clin. 59:225-49
5. RayG, HensonDE, Schwartz AM. 2010. Cigarette smoking as a cause of cancers other than lung cancer: an exploratory study using the SEER program. Chest 138:491-99
6. Proctor RN. 2001. Tobacco and the global lung cancer epidemic. Nat. Rev. Cancer 1:82-86 (Pubitemid 33741884)
7. Cent. Dis. Control Prev. 2009. Adult cigarette smoking in the United States: current estimates. http://www.cdc.gov/tobacco/data-statistics
8. Lákke A, Scharling H, Fabriclus P, Vestbo J. 2006. Developing COPD: a 25 year follow up study of the general population. Thorax 61:935-39 (Pubitemid 44787161)
9. O'Connor RJ, Cummings KM, Rees VW, Connolly GN, Norton KJ, et al. 2009. Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example. Cancer Epidemiol. Biomarkers Prev. 18:3334-48
10. Rodgman A, Perfetti TA. 2009. The Chemical Components of Tobacco and Tobacco Smoke 2009. Boca Raton, FL: Taylor and Francis
11. Hoffman D, Hoffman I. 1997. The changing cigarette, 1950-1996. Toxicol. Environ. Health 50:307-64
12. Wynder EL, Muscat JE. 1995. The changing epidemiology of smoking and lung cancer histology. Environ. Health Perspect. 103(Suppl. 8):143-48 (Pubitemid 26040890)
13. Chee-Keong T. 2009. The changing epidemiology of lung cancer. In Methods ofMolecular Biology. Cancer Epidemiology, ed. M Verma, 42:397-410. Totawa, NJ: Humana
14. Pickett G, Seagrave J, Boggs S, Polzin G, Richter P, Tesfaigzi Y. 2010. Effects of 10 cigarette smoke condensates on primary human airway epithelial cells by comparative gene and cytokine expression studies. Toxicol. Sci. 114:79-89
15. Jorgensen ED, Dozmorov I, Frank MB, Centla M, Albino AP. 2004. Global gene expression analysis of human bronchial epithelial cells treated with tobacco condensate. Cell Cycle 3:1154-68 (Pubitemid 40268634)
16. Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG. 2009. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiol. Biomarkers Prev. 18:3263-304
17. John L, Sharma G, Chaudhuri SP, Pillai B. 2005. Cigarette smoke extract induces changes in growth and gene expression of Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 338:1578-86 (Pubitemid 41608430)
18. Green RM, Gally F, Keeney JG, Alper S, Gao B, et al. 2009. Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS ONE 4:e6860
19. Maunders H, Patwardhan S, Phillips J, Clack A, Richter A. 2007. Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole cigarette smoke in vitro. Am. J. Physiol. Lung Cell Mol. Physiol. 292:1248-56
20. Robays LJ, Lanckacker EA, Moerloose KB, Maes T, Bracke KR, et al. 2009. Concomitant inhalation of cigarette smoke and aerosolized protein activates airway dendritic cells and induces allergic airway inflammation in a TLR-independent way. J. Immunol. 183:2758-66
21. Gangl K, Reininger R, Bernhard D, Campana R, Pree I, et al. 2009. Cigarette smoke facilitates allergen penetration across respiratory epithelium. Allergy 64:398-405
22. Toshinori Y, Tuder RM. 2007. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol. Rev. 87:1047-82 (Pubitemid 47084676)
23. Yao H, Edirisinghe I, Rajendrasozhan S, Yang SR, Caito S, et al. 2008. Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am. J. Physiol. Lung CellMol. Physiol. 294:1174-86
24. Cavarra E, Fardin P, Fineschi S, Ricciardi A, De Cunto G, et al. 2009. Early response of gene clusters is associated with mouse lung resistance or sensitivity to cigarette smoke. Am. J. Physiol. Lung Cell Mol. Physiol. 296:418-29
25. Leme AS, Berndt A, Williams LK, Tsaih SW, Szatkiewicz JP, et al. 2010. A survey of airway responsiveness in 36 inbred mouse strains facilitates gene mapping studies and identification of quantitative trait loci. Mol. Genet. Genomics 283:317-26
26. Bauer AK, Malkinson AM, Kleeberger SR. 2004. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am. J. Physiol. Lung Cell Mol. Physiol. 287:685-703
27. Slaughter DP, Southwick HW, Smejkal W. 1953. "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6:963-68
28. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL. 2007. Clinical implications and utility of field cancerization. Cancer Cell Int. 15:2
29. Steiling K, Ryan J, Brody JS, Spira A. 2008. The field of tissue injury in the lung and airway. Cancer Prev. Res. 1:396-403
30. Powell CA, Klares S, O'Connor G, Brody JS. 1999. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. Clinical Cancer Res. 5:2025-34 (Pubitemid 29399254)
31. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, et al. 1997. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89:1366-73 (Pubitemid 27418028)
32. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, et al. 1997. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. 89:857-62 (Pubitemid 27268450)
33. Zöchbauer-Müller S, Minna JD, Gazdar AF. 2002. AberrantDNAmethylation in lung cancer: biological and clinical implications. Oncologist 7:451-57 (Pubitemid 35266138)
34. Grepmeier U, DietmaierW, Merk J, Wild PJ, Obermann EC. 2005. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int. J. Oncol. 27:481-88
35. Spira A, Beane J, Shah V, Liu G, Schembri F, et al. 2004. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc. Natl. Acad. Sci. USA 101:10143-48 (Pubitemid 38891209)
36. Zhang L, Lee JJ, Tang H, Fan YH, Xiao L, et al. 2008. Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers. Prev. Res. 1:112-18
37. Crawford EL, Khuder SA, Durham SJ, Frampton M, Utell M, et al. 2000. Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma. Cancer Res. 60:1609-18 (Pubitemid 30183432)
38. Ammous Z, Hackett NR, Butler MW, Raman T, Dolgalev I, et al. 2008. Variability in small airway epithelial gene expression among normal smokers. Chest 133:1344-53 (Pubitemid 351892989)
39. Van Der Vaart H, Postma DS, Timens W, ten Hacken NHT. 2004. Acute effects of cigarette smoke on inflammation and oxidative stress. Thorax 59:713-21 (Pubitemid 39061538)
40. Beane J, Sebastiani P, Liu G, Brody JS, Lenburg ME, Spira A. 2007. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol. 8:R201
41. Honda O, Johkon T, Sekiguchi J, Tomiyama N, Mihara N, et al. 2009. Doubling time of lung cancer determined using three dimensional volumetric software: comparison of squamous cell carcinoma and adenocarcinoma. Lung Cancer 66:211-17
42. Salomaa ER, Sallinen S, Hiekkanen H, Lippo K. 2005. Delays in the diagnosis and treatment of lung cancer. Chest 128:2282-88 (Pubitemid 41507570)
43. Moody A, Muers M, Forman D. 2004. Delays in managing lung cancer. Thorax 59:29-32
44. Woodward RM, Brown RL, Steward ST, Cronin KA, Cutler DM. 2007. Value of medical interventions in the elderly. Cancer 110:2511-18
45. Spira A, Beane JE, Shah V, Steiling K, Liu G, et al. 2007. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat. Med. 13:361-66 (Pubitemid 46376687)
46. Blake DJ, Singh A, Kombairaju P, Malhotra D, Mariani TJ, et al. 2010. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation.Am. J. Respir. Cell Mol. Biol. 42:524-36
47. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. 2006. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-57 (Pubitemid 43128862)
48. Chang JT, CarvalhoC, Mori S, Bild AH, Gatza ML, et al. 2009. A genomic strategy to elucidatemodules of oncogenic pathway signaling networks. Mol. Cell 34:104-14
49. van't Veer LJ, Bernards R. 2008. Enabling personalized cancer medicine through analysis of geneexpression patterns. Nature 452:564-70 (Pubitemid 351483370)
50. Gustafson AM, Soldi R, Anderlind C, ScholandMB, Qian J, et al. 2010. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci. Transl. Med. 2:26ra25
51. RudinCM, Avila-Tang E, Harris CC, Herman JG, Hirsch FR, et al. 2009. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin. Cancer Res. 15:5646-61
52. Wang XR, Chiu YL, Qiu H, Au JS, Yu IT. 2009. The roles of smoking and cooking emissions in lung cancer risk among Chinese women in Hong Kong. Ann. Oncol. 20:746-51
53. Hadar T, Yaniv E, Shvili Y, Koren R, Shvero J. 2009. Histopathological changes of the nasal mucosa induced by smoking. Inhal. Toxicol. 21:1119-22
54. Bertram KM, Baglole CJ, Phipps RP, Libby RT. 2009. Molecular regulation of cigarette smoke inducedoxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration. Am. J. Physiol. Cell Physiol. 297:1200-10
55. Spivack SD, Hurteau GJ, Jain R, Kumar SV, Aldous KM, et al. 2004. Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res. 64:6805-13 (Pubitemid 39297945)
56. Jain RJ, Varma S, Hurteau GJ, Spivack SD. 2004. Buccal-lung comparison of quantitative expression of carcinogen and oxidant metabolism genes in human subjects. Chest 125:S107-8
57. Bhutani M, Pathak AK, Fan YH, Liu DD, Lee JJ, et al. 2008. Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev. Res. 1:39-44
58. Sridhar S, Schembri F, Zeskind J, Shah V, Gustafson AM, et al. 2008. Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics 9:259
59. Zhang X, Sebastiani P, Liu G, Schembri F, Zhang X, et al. 2010. Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium. Physiol. Genomics 41:1-8
60. Golpon HA, Coldren CD, Zamora MR, Cosgrove GP, Moore MD, et al. 2004. Emphysema lung tissue gene expression profiling. Am. J. Respir. Cell Mol. Biol. 31:595-600 (Pubitemid 39587488)
61. Chen ZH, Kim HP, Ryter SW, Choi AM. 2008. Identifying targets for COPD treatment through gene expression analyses. Int. J. COPD 3:359-70
62. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, et al. 2004. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc. Natl. Acad. Sci. USA 101:14895-900 (Pubitemid 39410771)
63. Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, et al. 2008. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am. J. Respir. Crit. Care Med. 177:402-11 (Pubitemid 351317583)
64. Spira A, Beane J, Pinto-Plata V, Kadar A, Liu G, et al. 2004. Gene expression profiling of human lung tissue from smokers with severe emphysema. Am. J. Respir. Cell Mol. Biol. 31:601-10 (Pubitemid 39587489)
65. Pierrou S, Broberg P, O'Donnell RA, Pawlowski K, Virtala R, et al. 2007. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. CareMed. 175:577-86 (Pubitemid 46438942)
66. Tilley AE, Harvey BG, Heguy A, Hackett NR, Wang R, et al. 2009. Down-regulation of the Notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease. Am. J. Respir. Crit. CareMed. 179:457-66
67. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. 2006. The Connectivity Map: using geneexpression signatures to connect small molecules, genes, and disease. Science 313:1929-35 (Pubitemid 44497995)
68. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, et al. 2007. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. USA 104:15858-63 (Pubitemid 350035389)
69. Skillrud DM, Offord KP, Miller RD. 1986. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann. Intern. Med. 105:503-507 (Pubitemid 16003992)
70. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. 1987. Airways obstruction and the risk for lung cancer. Ann. Intern. Med. 106:512-18 (Pubitemid 17095034)
71. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, et al. 2009. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS ONE 4:e7380
72. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, et al. 2008. Association of radiographic emphysema and airflow obstruction with lung cancer. Am. J. Respir. Crit. Care Med. 178:738-44
73. Brody JS, Spira A. 2006. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc. Am. Thorac. Soc. 3:535-37 (Pubitemid 44285546)
74. Lee G, Walser TC, Dubinett SM. 2009. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr. Opin. Pulm. Med. 15:303-7
75. Yao H, Rahman I. 2009. Current concepts on the role of inflammation in COPD and lung cancer. Curr. Opin. Pharmacol. 9(4):375-83
76. Manzel LJ, Shi L, O'Shaughnessy PT, Thorne PS, Look DC. 2010. Cigarette smoke inhibition of the NF-κB-dependent response to bacteria in the airway. Am. J. Respir. Cell Mol. Biol. In press
77. Moghaddam SJ, Li H, Cho SN, Dishop MK, Wistuba II, et al. 2009. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am. J. Respir. Cell Mol. Biol. 40:443-53
78. HoughtonAM, RzymkiewiczDM, JiH, Gregory AD, Egea EE, et al. 2010. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 16:219-23
79. Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. 2009. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J. Natl. Cancer Inst. 101:554-59
80. Zhang C. 2008. MicroRNomics: a newly emerging approach for disease biology. Physiol. Genomics 33:139-47 (Pubitemid 351629522)
81. Inui X, Martello G, Piccolo S. 2010. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11:252-63
82. Lin P-Y, Yu S-L, Yang P-C. 2010. MicroRNA in lung cancer. Br. J. Cancer. In press
83. GaoW, Yu Y, Cao H, Shen H, Li X, et al. 2010. Deregulated expression of miR-21, miR-143 and miR- 181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed. Pharmacother. 64:399-408
84. Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, et al. 2009. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur. Respir. J. 33:352-59
85. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, et al. 2009. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl. Acad. Sci. USA 106:2319-24
86. Ushijima T. 2007. Epigenetic field for cancerization. J. Biochem. Mol. Biol. 40:142-50 (Pubitemid 46515191)
87. Sharma S, Kelly TK, Jones PA. 2010. Epigenetics in cancer. Carcinogenesis 31:27-36
88. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, Belinsky SA. 2004. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res. 64:3844-48 (Pubitemid 38697294)
89. Guo M, House MG, Hooker C, Han Y, Heath E, et al. 2004. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin. Cancer Res. 10:5131-36 (Pubitemid 39099787)
90. Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L. 2002. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res. 62:351-55 (Pubitemid 34106401)
91. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, et al. 2002. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 62:2370-77 (Pubitemid 34411720)
92. Adcock IM, Tsaprouni L, Bhavsar P, Ito K. 2007. Epigenetic regulation of airway inflammation. Curr. Opin. Immunol. 19:694-700 (Pubitemid 350236802)
93. Lambrechts D, Buysschaert I, Zanen P, Coolen J, Lays N, et al. 2010. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. Am. J. Respir. Crit. Care Med. 181:486-93
94. Dehkordi O, Rose JE, Balan KV, Millis RM, Bhatti B, Jayam-Trouth A. 2010. Co-expression of nAChRs and molecules of the bitter taste transduction pathway by epithelial cells of intrapulmonary airways. Life Sci. 86:281-88
95. Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, et al. 2010. The tobacco-specific carcinogenNNKinduces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J. Clin. Investig. 120:521-32
96. Paliwal A, Vaissière T, Krais A, Cuenin C, Cros MP, et al. 2010. AberrantDNAmethylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res. 70:2779-88
97. Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG, Writ, Comm. AACR Task Force Tobacco Cancer. 2010. Tobacco and cancer: an American Association for Cancer Research policy statement. Cancer Res. 70:3419-30
98. Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, et al. 2006. Smoking and cancerrelated gene expression in bronchial epithelium and non-small-cell lung cancers. J. Pathol. 210:192-204 (Pubitemid 44463934)
99. Tan XL, Wang T, Xiong S, Kumar SV, Han W, Spivack SD. 2009. Smoking-related gene expression in laser capture-microdissected human lung. Clin. Cancer Res. 15:7562-70
100. Franklin WA, Gazdar AF, Hanley J, et al. 1997. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J. Clin. Investig. 100:2133-37 (Pubitemid 27459370)
101. Chang YL, Wu CT, Lin SC, Hsiao CF, Jou YS, Lee YC. 2007. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. Clin. Cancer Res. 13:52-58
102. Wang X, Christiani DC, Mark EJ, Nelson H, Wiencke JK, et al. 1999. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma. Cancer 85:1734-39 (Pubitemid 29169674)
103. Mitsudomi T, Yatabe Y, Koshikawa T, Hatooka S, Shinoda M, et al. 1997. Mutations of the p53 tumor suppressor gene as clonalmarker for multiple primary lung cancers. J. Thorac. Cardiovasc. Surg. 114:354-60 (Pubitemid 27400868)
104. Metzker ML. 2010. Sequencing technologies: the next generation. Nat. Rev. Genet. 11:31-46
105. Wang R, Gerstein M, SnyderM. 2009. Ref-Seq: a revolutionary toll for transcriptomics. Nat. Rev. Genet. 10:57-63
106. Wang X, Chorley BN, Pittman GS, Kleeberger SR, Brothers J, et al. 2010. Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer. PLoS ONE 5:e11934
107. Kazutetsu A, Nagai A. 2009. Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 6:596-601
108. Freund A, Orjalo AV, Desprez P-Y, Campisi J. 2010. Inflammatory networking during cellular senescence: causes and consequences. Cell Trends Mol. Med. 16:238-46
109. Davalos AR, Coppe J-P, Campisi J, Deprez P-Y. 2010. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis 29:273-83